Pulmonary arterial hypertension market to reach $9.3 bn in 7MM by 2034
GlobalData’s latest report reveals that the US market is the largest PAH market in the 7MM, accounting for 76.3 per cent of global…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
pulmonary arterial hypertension
Zydus Cadila gets final USFDA nod for Macitentan Tablets and eligibility for 180-day shared…
Macitentan is used to manage the symptoms of pulmonary arterial hypertension
Alembic Pharma subsidiary, Alembic Global Holding SA gets USFDA final nod for Treprostinil injection
Treprostinil injection is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with…
Gmax BioPharm looking to enter competitive PAH market with early stage drug GMA301
In preclinical testing on animal models, GMA301 showed improved efficacy in lowering right ventricular pressure and hypertrophy,…
Alembic Pharma gets tentative USFDA approval for Treprostinil injection
It is indicated for the treatment of pulmonary arterial hypertension to diminish symptoms associated with exercise